These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 36525883)
1. Room to improve: The diagnostic journey of Spinal Muscular Atrophy. Carter M; Tobin A; Coy L; McDonald D; Hennessy M; O'Rourke D Eur J Paediatr Neurol; 2023 Jan; 42():42-46. PubMed ID: 36525883 [TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy in Ghanaian children confirmed by molecular genetic testing: a case series. Hammond CK; Oppong E; Ameyaw E; Dogbe JA Pan Afr Med J; 2023; 46():78. PubMed ID: 38282771 [TBL] [Abstract][Full Text] [Related]
3. Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening. Romanelli Tavares VL; Mendonça RH; Toledo MS; Hadachi SM; Grindler CM; Zanoteli E; Marques W; Oliveira ASB; Breinis P; Morita MDPA; França MC Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062637 [TBL] [Abstract][Full Text] [Related]
4. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study. Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA Lancet Child Adolesc Health; 2023 Mar; 7(3):159-170. PubMed ID: 36669516 [TBL] [Abstract][Full Text] [Related]
5. Spinal Muscular Atrophy Treatments, Newborn Screening, and the Creation of a Neurogenetics Urgency. Butterfield RJ Semin Pediatr Neurol; 2021 Jul; 38():100899. PubMed ID: 34183144 [TBL] [Abstract][Full Text] [Related]
6. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years. Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Journey of Korean Patients with Spinal Muscular Atrophy. Kim SH; Lee CS; Lee SR; Choi YC; Kim SW; Shin HY; Park HJ Yonsei Med J; 2024 Oct; 65(10):572-577. PubMed ID: 39313447 [TBL] [Abstract][Full Text] [Related]
8. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era. Zettler B; Estrella E; Liaquat K; Lichten L J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741 [TBL] [Abstract][Full Text] [Related]
9. The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747 [TBL] [Abstract][Full Text] [Related]
10. [Expert consensus on newborn screening for spinal muscular atrophy (2023 edition)]. ; Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2075-2081. PubMed ID: 37455125 [TBL] [Abstract][Full Text] [Related]
11. Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies. Int J Mol Sci; ; . PubMed ID: 37834320 [TBL] [Abstract][Full Text] [Related]